Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SOLV · against 132 other Healthcare companies of similar size
Ranked #8 of 133 · scores higher than 94% of peers
Bars: peers in each 10-point band of the valuation score11 peers with a valuation score of 90–100, including SOLV · Click a bar to see the companies
Mainly thanks to its earnings yield, which is stronger than most Healthcare peers.
| Metric | SOLV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 131 reported | 9.7% | 2.8% | 98% | 30% | |
| EBITDA yieldHigher is better · 134 reported | 5.9% | 4.8% | 57% | 50% | |
| Free cash flow yieldHigher is better · 88 reported | -0.8% | 2.9% | 23% | 20% | |
| Book yieldHigher is better · 131 reported | 33.3% | 21.0% | 70% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 2 | 10.4B USD | 96 | 64 | |
| 3 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 3 | 21.5B USD | 95 | 60 | |
| 5 | 11.6B USD | 94 | 58 | |
| 5 | 68.0B BRL (≈$12.2B) | 94 | 67 | |
| 7 | 1.09T JPY (≈$7.4B) | 93 | 75 | |
| 8 | 11.6B USD | 92 | 57 | |
| 8 | 14.4B USD | 92 | 71 | |
| 10 | 1.30T JPY (≈$8.8B) | 91 | 71 | |
| 11 | 10.0B USD | 90 | 64 | |
| 12 | 66.0B BRL (≈$11.9B) | 89 | 55 | |
| 13 | 2.57T JPY (≈$17.5B) | 88 | 62 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score